Objective:

To discuss the integration and optimization of minimally invasive glaucoma surgery (MIGS) in ambulatory surgical centers (ASCs).

Approach:

• MIGS Implementation: MIGS is positioned as a core capability in ASCs, enhancing clinical outcomes, patient experience, and ASC economics.
• Operational Efficiency: Focus on execution, understanding the clinical landscape, controlling device costs, and optimizing intraoperative workflow.
• Scheduling and Training: Implement tiered scheduling and ensure team training to minimize operational disruptions.

Key Findings:

• MIGS can be performed alongside cataract surgery with minimal additional time and resource burden.
• The incorporation of MIGS can enhance OR throughput and profitability in ASCs.
• Different MIGS mechanisms have varying operational demands and cost profiles.

Interpretation:

MIGS is a viable and efficient addition to ASC offerings, addressing the glaucoma burden while maintaining operational efficiency.

Limitations:

• Challenges with device visualization and procedural complications may arise.
• Careful patient counseling regarding potential side effects of sustained-release drug delivery systems is necessary.

Conclusion:

MIGS represents an advancement in glaucoma treatment within ASCs.